Alterations of Long-Chain Free Fatty Acid and Magnesium Concentrations in Acute Myocardial Infarction

Archives of Internal Medicine

Volumn 141, Issue 4, 1981, Pages 441-443

  Flink, Edmund B ^a   Brick, James E ^a   Shane, Stanley R ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALCOHOL; ETACRYNIC ACID; FATTY ACID; FUROSEMIDE; GLUCOSE; INSULIN; ISOPRENALINE; MAGNESIUM; NICOTINIC ACID; OLEIC ACID; POTASSIUM; PROPRANOLOL;

HEART; HEART INFARCTION; HEART MUSCLE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY;

ADULT; AGED; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMAN; MAGNESIUM; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0019427938     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1981.00340040037014     Document Type: Article

References (33)

1. Kurien VA, Oliver MF: Serum free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet 2:122-127, 1966.
2. Oliver MF, Kurien VA, Greenwood TW: Relation between serum free fatty-acids and arrhythmias and death after acute myocardial infarction. Lancet 1:710-714, 1968.
3. Gupta DK, Jewitt DE, Young R, et al: Increased plasma free fatty acid concentration and their significance in patients with acute myocardial infarction. Lancet 2:1209-1213, 1969.
4. Kurien VA, Yates PA, Oliver MF: Free fatty acids, heparin and arrhythmias during experimental myocardial infarction. Lancet 2:185-187, 1969.
5. Opie LH, Tansey M, Kennelly BM: Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty acid concentrations. Lancet 2:890-892, 1977.
6. Rowe MJ, Neilson JMM, Oliver MF: Control of ventricular arrhythmias during myocardial infarction by an antilipolytic treatment using a nicotinic acid analogue. Lancet 1:295-300, 1975.
7. Rogers WJ, Stanley AW, Breinig JB, et al: Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 92:441-454, 1976.
8. Rogers WJ, Segall PH, McDaniel HG, et al: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction: Effects on myocardial hemodynamics, substrates and rhythms. Am J Cardiol 43:801-809, 1979.
9. Abraham AS, Eylath U, Weinstein M, et al: Serum magnesium levels in patients with acute myocardial infarction. N Engl J Med 296:862-863, 1977.
10. Dyckner T: Serum magnesium in acute myocardial infarction. Acta Med Scand, to be published.
11. Shug AL, Shrag E: A proposed mechanism for fatty acid effects on energy metabolism of the heart. J Lab Clin Med 81:214-218, 1973.
12. Mjos D, Kjekshus J: Increased local metabolic rate by free fatty acids in the intact dog heart. Scand J Clin Lab Invest 28:389-393, 1971.
13. Rogers WJ, McDaniel HG, Moraski RE, et al: Effect of heparininduced free fatty acid elevation on myocardial oxygen consumption in man. Am J Cardiol 40:365-372, 1977.
14. Flink EB, Shane SR, Scobbo RR, et al: Relationship of free fatty acid and magnesium in ethanol withdrawal in dogs. Metabolism 28:858-865, 1979.
15. Rayssiguier Y: Hypomagnesemia resulting from adrenaline infusion in ewes: Its relation to lipolysis. Horm Metab Res 9:309-318, 1977.
16. Remington RF, Schork J: The Sign Test: Statistics With Application to the Health Sciences. Englewood Cliffes, NJ, Prentice-Hall Inc, 1970, chap 12, pp 316-318.
17. Vetter NJ, Adams W, Strange RC, et al: Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1:284-288, 1974.
18. Gordon RS Jr, Cherkes A: Unesterified fatty acid in human blood plasma. J Clin Invest 35:206-212, 1956.
19. Burns TW, Langley FE, Terry BE, et al: The role of free fatty acids in the regulation of lipolysis by human adipose tissue cells. Metabolism 27:1755-1762, 1978.
20. Nuzum RA, VanDyke K, Flink EB: Use of luciferin-luciferase to measure serum magnesium: Inhibition of light production by heparin and fatty acids. Microchem J 24:409-420, 1979.
21. Flink EB, Marano GD, Morabito R, et al: Plasma free fatty acids and magnesium in the alcoholism withdrawal syndrome. Curr Alcoholism 1:329-340, 1977.
22. Seller RH, Cangiano J, Kim KE, et al: Digitalis toxicity and hypomagnesemia. Am Heart J 79:57-68, 1970.
23. Loeb HS, Pietras RP, Gunnar RM, et al: Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Circulation 37:210-215, 1968.
24. Ricketts HH, Denison EK, Haywood LJ: Unusual T-wave abnormality: Repolarization alternans associated with hypomagnesemia, acute alcoholism, and cardiomyopathy. JAMA 207:365-366, 1969.
25. Iseri LT, Freed J, Bures AR: Magnesium deficiency and cardiac disorders. Am J Med 58:837-846, 1975.
26. Burch GE, Giles TD: The importance of magnesium deficiency in cardiovascular disease. Am Heart J 94:649-657, 1977.
27. Fisher J, Abrams J: Life-threatening ventricular tachyarrhythmias in delirium tremens. Arch Intern Med 137:1238-1241, 1977.
28. Dyckner T, Wester PO: Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J 97:12-18, 1979.
29. Chadda KD, Lichstein E, Gupta P: Hypomagnesemia and refractory cardiac arrhythmias in a nondigitalized patient. Am J Cardiol 31:98-100, 1973.
30. Milner G, Johnson J: Hypomagnesemia and delirium tremens: Report of a case with fatal outcome. Am J Psychiatr 122:701-702, 1965.
31. Sodi-Pallares D, Testelli MR, Fishleder BL, et al: Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 9:166-181, 1962.
32. Chiong MA, West R, Parker JO: The protective effect of glucose-insulin-potassium on the response to atrial pacing. Circulation 54:37-46, 1976.
33. Lim P, Jacob E: Magnesium deficiency in patients on long term diuretic therapy for heart failure. Br Med J 3:620, 1972.